Actinium Pharmaceuticals, Inc. — Director's Dealing 2013

Jan 3, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cactus Ventures, Inc. (CTVN)
CIK: 0001388320
Period of Report: 2012-12-28

Reporting Person: GUAGENTI ENZA (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to purchase common stock	$0.784	2022-02-10	Options (8325)		Direct
Options to purchase common stock	$0.784	2022-08-15	Options (24975)		Direct

Footnotes

F1: Options granted on February 10, 2012 to purchase an aggregate of 8,325 shares of common stock. A total of 28% of the options will vest one year from the grant date, and 2% per month thereafter.

F2: Options granted on August 15, 2012 to purchase an aggregate of 24,975 shares of common stock. Options vest at a rate of 2% per month. As of the date of this report, 2,248 options have vested pursuant to the August 15, 2012 grant.